Genfit S.A.
GNFTY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$471.83M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $471.83 Million |
|---|---|
| Enterprise Value | $537.28 Million |
| Earnings per Share | $0.03 |
| Beta | 1.19 |
| Outstanding Shares | 49,784,805 |
Return
| Return on Equity | 284.57% |
|---|---|
| Return on Assets | -91.75% |
| Return on Invested Capital | -146.36% |
Valuation & Multiples
| P/E Ratio | -4.25 |
|---|---|
| PEG | -2.62 |
| Price to Sales | 8.95 |
| Price to Book Ratio | -8.95 |
| Enterprise Value to Revenue | 5.56 |
| Enterprise Value to EBIT | -5.71 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | -3.62 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Genfit
130 employees
CEO: Pascal Prigent
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in...